Sellas Life Sciences Competitors and Similar CompaniesClear all
Marker Therapeutics's competitors and similar companies include Bionomics.
 Marker Therapeutics Marker Therapeutics is a biopharmaceutical company engaged in the discovery and development of immunotherapeutics for the treatment of cancer, infectious diseases, autoimmune disorders, and transplant tissue rejection. |  Bionomics Bionomics is a clinical-stage biopharmaceutical company developing ion channels targeting drug candidates designed for patients suffering from central nervous system (CNS) disorders. | |
Founding Date | Founding Date 2018 | Founding Date 1996 |
Type | Type Public | Type Subsidiary |
Tags | ||
Locations | Locations Houston, US HQ | Locations Eastwood, AU HQ |
Employees | Employees 888% decrease | Employees 7 |
Financial | ||
Revenue (est.) | Revenue (est.) $3.5m (FY, 2025) | Revenue (est.) $264k (FY, 2022) |
Net income | Net income ($12.2m) (FY, 2025) | Net income ($21.8m) (FY, 2022) |
For sources of this data, please see the company profile
View Company Profiles
Bionomics
HQ
Eastwood, AU
Bionomics is a clinical-stage biopharmaceutical company developing ion channels targeting drug candidates designed for patients suffering from central nervous system (CNS) disorders.
View company